← Browse by Condition
Medical Condition

cystitis recurrent

Total Trials
3
Recruiting Now
3
Trial Phases
Phase 4, Phase 1

ClinicalMetric tracks all active clinical trials for cystitis recurrent sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.

  • Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
  • Phase 1–4 studies from early safety trials to post-marketing surveillance
  • NIH, pharmaceutical sponsor, and academic medical center studies worldwide
  • AI-powered plain-language summary available for every trial listing
Trial Phases
Phase 1
1
Phase 4
1
Top Sponsors
University of Texas Southwestern Medical Center 2 trials
Mahidol University 1 trial
NCT07186465 Phase 4
Recruiting

Microbiome-Modulating Prophylaxis RCT: Antibiotic vs Gynoflor in Postmenopausal Women With Recurrent Cystitis

Enrollment
100 pts
Location
Thailand
Sponsor
Mahidol University
View Trial →
NCT06940622
Recruiting

A Trial of D-mannose for the Prophylaxis of Recurrent Urinary Tract Infections

Enrollment
90 pts
Location
United States
Sponsor
University of Texas Southweste...
View Trial →
NCT06907199 Phase 1
Recruiting

Daily Nitrofurantoin Versus Bladder Fulguration Plus Daily Nitrofurantoin for Women With Recurrent Urinary Tract Infections

Enrollment
104 pts
Location
United States
Sponsor
University of Texas Southweste...
View Trial →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology